Up next

Autoplay

Novel therapies on the horizon for cutaneous T-cell lymphoma

2 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Speaking from the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, Rudolf Stadler, MD, PhD, of the University Medical Center Minden, Minden, Germany, discusses new therapy options for cutaneous T-cell lymphoma, including brentuximab vedotin and mogamulizumab. In addition, Prof. Stadler discusses promising targets for therapeutic antibodies.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay